Kiran Mazumdar-Shaw is No 2 on global 'Medicine Maker Power List' 2015

She is the only India-based business leader featuring on the list

BS Reporter Bengaluru
Last Updated : May 12 2015 | 7:21 PM IST
Kiran Mazumdar-Shaw, Chairperson of biopharmaceutical major Biocon Ltd, has been ranked No. 2 on 'The Medicine Maker Power List' 2015, an index of the 100 most influential people across the globe in the field of medicine.

Mazumdar-Shaw appears on the list alongside global leaders from the industry, including CEOs, professors, Nobel Prize-winning researchers and many other celebrated scientists from the pharmaceutical world.

The Top 5 on 'The Medicine Maker Power List' include: Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, USA; Kiran Mazumdar-Shaw, Chairperson & MD, Biocon; Andrew Witty, CEO, GlaxoSmithKline; Arthur D Levinson, CEO, Calico and Heather Bresch, CEO, Mylan.

The list also includes names like Pascal Soriot, CEO, AstraZeneca; Robert A Bradway, Chairman & CEO, Amgen; Ian C Read, Chairman, Pfizer; Prof. Tyler Jacks, Koch Institute for Integrative Cancer Research; Charles Cooney, Massachusetts Institute of Technology, USA; Harold Varmus, Weil Cornell Medical College and many more.

Mazumdar-Shaw is the only India-based business leader featuring on the list. The drug maker is a UK-based publication that is distributed worldwide to a targeted European and North American industry professionals. The power list has been compiled from reader nominations with the help of expert judges and is based entirely on merit.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 12 2015 | 7:00 PM IST

Next Story